Welcome back to Stockhouse Member Sign In
Send my password
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
TSO3 (T.TOS) opens the books on Q2 2014 with 254% increase in quarterly sales and traders buy in
"Depending on who the channel partner is, and how the deal is structured, it could easily double from there in the next 6 months I would...
I'm going with the Canaccord analyst target of $1.75, which should get moved up once actual FDA clearance is given. Depending on who the...
Wow care to explain with actual projections??
$30.00 in 2 years
How high do you see this going ?